Skip to main content
. 2022 Apr 14;13:869780. doi: 10.3389/fendo.2022.869780

Figure 2.

Figure 2

Bidirectional Eph-ephrin signaling increases or decreases insulin release in a glucose-dependent manner: (A) eprin-Eph forward signaling attenuates insulin secretion under basal conditions, while Eph-ephrin reverse signaling potentiates insulin secretion under high glucose conditions. (B) β cell-α cell ephrin-Eph signaling also decreases glucagon secretion.